December 12, 2023
Amanda Su
Share
https://www.journal-of-hepatology.eu/action/showPdf?pii=S0168-8278%2821%2902234-0
Can Efruxifermin Reverse Fibrosis in Compensated MASH Cirrhosis?
April 28, 2026
Pediatric Autoimmune Hepatitis: Is Treatment Withdrawal Possible and Safe?
March 16, 2026
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
March 9, 2026
